Navigo (Q3 review) - Nascent recovery

Redeye updates its estimates and valuation following Navigo releasing its Q3 2025 report. Adjusted EBIT beat our projection, and cyclical subsidiaries seem to face a nascent market recovery. Nordisk Bergteknik’s share price has continued to rise since the end of Q3, boding well for NAV growth.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/